(Q34107623)

English

Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma

scientific article

  • Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma
In more languages
default for all languages
No label defined

No description defined

Statements

Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma (English)
Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma (English)
0 references
0 references
Stanislaw M Mikulski
Stanislaw M. Mikulski
0 references
John J. Costanzi
0 references
Robert N. Taub
0 references
1 January 2002
January 2002
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit